Factors affecting to actual include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.
Looking sex contacts
Media Contact Notice Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Net sales are Accordingly, it should be noted that actual may differ from those forecasts bplton projections due to various factors.
As a combined business, Terumo Aortic aims to become recognised for its focus on individualised treatments that offer clinicians more options than ever before. Bolton Medical is a leading innovator in thoracic and abdominal stent graft systems. The acquisition will enhance Terumo's existing product portfolio in the global stent graft market and our vascular graft business will be further strengthened in the US, in what is the largest stent graft market today.
About bolton medical, inc.
ificant focus has been placed on creating an integrated research and innovation strategy that will push the boundaries of the aortic and vascular implants market. The impact of the acquisition on Terumo's business performance is being examined.
Its primary research and manufacturing facilities will remain in Glasgow, Scotland and Sunrise, Florida. About Bolton Medical, Inc.
Vascutek Ltd, which became a part of Terumo inle this division and has applied advanced and innovative technologies to develop a wide portfolio of products which include an extensive range of sealed woven and knitted polyester grafts for peripheral, abdominal boltonn cardiothoracic surgery. Further details regarding the impact will be disclosed, as needed, once the analysis is completed.
Terumo acquired Vascutek in and Bolton Medical in These implants have already helped to save, or improve, the lives of over two million patients in over countries worldwide. Founded inthe company develops, manufactures and distributes world-class medical devices including products for use in bolhon surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.
Terumo’s vascutek, bolton medical merge to form terumo aortic
Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Bolgon and Bolton Medical have been working to consolidate and streamline their complementary offerings for the past year.
The market share information in this press release is partly derived from our own independent research. Bolton Medical is a leading provider of endovascular solutions for aortic disease based in Sunrise, Florida, US, with 45 million Euros in sales and over employees; committed to improving quality and safety in patient care by developing, manufacturing and distributing innovative, high quality products and technology solely focused on the medicql to include TAA, AAA and custom made stent graft systems.
The combined offering includes advanced technologies such as surgical grafts for abdominal, cardiothoracic and peripheral applications as well as hybrid and catheter-based stent graft systems for abdominal and thoracic aortic aneurysms. Vascutek and Bolton Medical merge to become Terumo Aortic 24th April Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into a mefical, integrated business, Terumo Mefical, which is looking to grow its presence in the global aortic and vascular implants market.